Garden State Investment Advisory Services LLC Bridge Bio Pharma, Inc. Transaction History
Garden State Investment Advisory Services LLC
- $336 Billion
- Q4 2024
A detailed history of Garden State Investment Advisory Services LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 11,368 shares of BBIO stock, worth $356,955. This represents 0.09% of its overall portfolio holdings.
Number of Shares
11,368
Previous 11,588
1.9%
Holding current value
$356,955
Previous $295 Million
5.73%
% of portfolio
0.09%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$793 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$789 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$391 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$194 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.65B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...